Persons with dispensed medicines; age and sex
Sex | Ages | Medicine group (ATC) | Periods | Persons with medicines, relative (%) |
---|---|---|---|---|
Total male and female | Total age | A Alimentary tract and metabolism | 2022* | 24.87 |
Total male and female | Total age | A02B Drugs for peptic ulcer and gord | 2022* | 12.48 |
Total male and female | Total age | A03B Belladonna and derivatives, plain | 2022* | 0.02 |
Total male and female | Total age | A03E Antispasmodics and anticholinergics | 2022* | 0.00 |
Total male and female | Total age | A04 Antiemetics and antinauseants | 2022* | 0.74 |
Total male and female | Total age | A04A Antiemetics and antinauseants | 2022* | 0.74 |
Total male and female | Total age | A05 Bile and liver therapy | 2022* | 0.10 |
Total male and female | Total age | A05C Bile therapy drugs and lipotropics | 2022* | 0.00 |
Total male and female | Total age | A10A Insulins and analogues | 2022* | 1.54 |
Total male and female | Total age | A11C Vit A and D, incl.combin.of the two | 2022* | 5.55 |
Total male and female | Total age | A11D Vitamin B1,and with vit. B6 and B12 | 2022* | 0.01 |
Total male and female | Total age | A16A Oth.aliment.tract and metabol.prod. | 2022* | 0.02 |
Total male and female | Total age | B Blood and blood forming organs | 2022* | 13.22 |
Total male and female | Total age | B02B Vitamin k and other hemostatics | 2022* | 0.08 |
Total male and female | Total age | B03B Vitamin B12 and folic acid | 2022* | 1.69 |
Total male and female | Total age | B05A Blood and related products | 2022* | 0.00 |
Total male and female | Total age | B05Z Hemodialytics and hemofiltrates | 2022* | 0.00 |
Total male and female | Total age | C01B Antiarrhythmics, class I and III | 2022* | 0.39 |
Total male and female | Total age | C07B Beta blocking agents and thiazides | 2022* | 0.10 |
Total male and female | Total age | D02 Emollients and protectives | 2022* | 6.16 |
Total male and female | Total age | D02A Emollients and protectives | 2022* | 6.16 |
Total male and female | Total age | D08 Antiseptics and disinfectants | 2022* | 0.01 |
Total male and female | Total age | D08A Antiseptics and disinfectants | 2022* | 0.01 |
Total male and female | Total age | G Genito urinary system and sex hormones | 2022* | 6.73 |
Total male and female | Total age | G03B Androgens | 2022* | 0.14 |
Total male and female | Total age | G03E Androgens / female sex hormon.comb. | 2022* | 0.00 |
Total male and female | Total age | G03H Antiandrogens | 2022* | 0.02 |
Total male and female | Total age | H05A Parathyroid hormones and analogues | 2022* | 0.01 |
Total male and female | Total age | J01E Sulfonamides and trimethoprim | 2022* | 0.84 |
Total male and female | Total age | J06 Immune sera and immunoglobulins | 2022* | 0.06 |
Total male and female | Total age | J07C Bacterial and viral vaccines,combi. | 2022* | 0.00 |
Total male and female | Total age | L Antineoplastic and immunomodul. agents | 2022* | 2.02 |
Total male and female | Total age | L01F Monoclonal antbodies and a.d.c. | 2022* | 0.00 |
Total male and female | Total age | L02A Hormones and related agents | 2022* | 0.22 |
Total male and female | Total age | M02A Joint and muscular pain top. prod. | 2022* | 0.00 |
Total male and female | Total age | M05B Bone structure and mineralization . | 2022* | 1.23 |
Total male and female | Total age | N02B Other analgesics and antipyretics | 2022* | 0.02 |
Total male and female | Total age | N05C Hypnotics and sedatives | 2022* | 1.33 |
Total male and female | Total age | P01C Leishmaniasis and trypanosomiasis | 2022* | 0.00 |
Total male and female | Total age | P03B Insecticides and repellents | 2022* | 0.00 |
Total male and female | Total age | R05 Cough and cold preparations | 2022* | 3.27 |
Total male and female | Total age | R05F Cough suppressants and expectorants | 2022* | 0.00 |
Total male and female | Total age | S01F Mydriatics and cycloplegics | 2022* | 0.17 |
Total male and female | Total age | S01G Decongestants and antiallergics | 2022* | 1.39 |
Total male and female | 0 to 15 years | A Alimentary tract and metabolism | 2022* | 6.47 |
Total male and female | 0 to 15 years | A02B Drugs for peptic ulcer and gord | 2022* | 0.50 |
Total male and female | 0 to 15 years | A03B Belladonna and derivatives, plain | 2022* | 0.00 |
Total male and female | 0 to 15 years | A03E Antispasmodics and anticholinergics | 2022* | 0.00 |
Total male and female | 0 to 15 years | A04 Antiemetics and antinauseants | 2022* | 1.20 |
Total male and female | 0 to 15 years | A04A Antiemetics and antinauseants | 2022* | 1.20 |
Total male and female | 0 to 15 years | A05 Bile and liver therapy | 2022* | 0.01 |
Total male and female | 0 to 15 years | A05C Bile therapy drugs and lipotropics | 2022* | 0.00 |
Total male and female | 0 to 15 years | A10A Insulins and analogues | 2022* | 0.15 |
Total male and female | 0 to 15 years | A11C Vit A and D, incl.combin.of the two | 2022* | 0.35 |
Total male and female | 0 to 15 years | A11D Vitamin B1,and with vit. B6 and B12 | 2022* | 0.00 |
Total male and female | 0 to 15 years | A16A Oth.aliment.tract and metabol.prod. | 2022* | 0.02 |
Total male and female | 0 to 15 years | B Blood and blood forming organs | 2022* | 0.68 |
Total male and female | 0 to 15 years | B02B Vitamin k and other hemostatics | 2022* | 0.01 |
Total male and female | 0 to 15 years | B03B Vitamin B12 and folic acid | 2022* | 0.06 |
Total male and female | 0 to 15 years | B05A Blood and related products | 2022* | 0.00 |
Total male and female | 0 to 15 years | B05Z Hemodialytics and hemofiltrates | 2022* | 0.00 |
Total male and female | 0 to 15 years | C01B Antiarrhythmics, class I and III | 2022* | 0.00 |
Total male and female | 0 to 15 years | C07B Beta blocking agents and thiazides | 2022* | 0.00 |
Total male and female | 0 to 15 years | D02 Emollients and protectives | 2022* | 7.63 |
Total male and female | 0 to 15 years | D02A Emollients and protectives | 2022* | 7.63 |
Total male and female | 0 to 15 years | D08 Antiseptics and disinfectants | 2022* | 0.00 |
Total male and female | 0 to 15 years | D08A Antiseptics and disinfectants | 2022* | 0.00 |
Total male and female | 0 to 15 years | G Genito urinary system and sex hormones | 2022* | 0.92 |
Total male and female | 0 to 15 years | G03B Androgens | 2022* | 0.01 |
Total male and female | 0 to 15 years | G03E Androgens / female sex hormon.comb. | 2022* | 0.00 |
Total male and female | 0 to 15 years | G03H Antiandrogens | 2022* | 0.00 |
Total male and female | 0 to 15 years | H05A Parathyroid hormones and analogues | 2022* | 0.00 |
Total male and female | 0 to 15 years | J01E Sulfonamides and trimethoprim | 2022* | 0.66 |
Total male and female | 0 to 15 years | J06 Immune sera and immunoglobulins | 2022* | 0.11 |
Total male and female | 0 to 15 years | J07C Bacterial and viral vaccines,combi. | 2022* | 0.00 |
Total male and female | 0 to 15 years | L Antineoplastic and immunomodul. agents | 2022* | 0.14 |
Total male and female | 0 to 15 years | L01F Monoclonal antbodies and a.d.c. | 2022* | 0.00 |
Total male and female | 0 to 15 years | L02A Hormones and related agents | 2022* | 0.04 |
Total male and female | 0 to 15 years | M02A Joint and muscular pain top. prod. | 2022* | 0.00 |
Total male and female | 0 to 15 years | M05B Bone structure and mineralization . | 2022* | 0.00 |
Total male and female | 0 to 15 years | N02B Other analgesics and antipyretics | 2022* | 0.00 |
Total male and female | 0 to 15 years | N05C Hypnotics and sedatives | 2022* | 0.34 |
Total male and female | 0 to 15 years | P01C Leishmaniasis and trypanosomiasis | 2022* | 0.00 |
Total male and female | 0 to 15 years | P03B Insecticides and repellents | 2022* | 0.00 |
Total male and female | 0 to 15 years | R05 Cough and cold preparations | 2022* | 0.11 |
Total male and female | 0 to 15 years | R05F Cough suppressants and expectorants | 2022* | 0.00 |
Total male and female | 0 to 15 years | S01F Mydriatics and cycloplegics | 2022* | 0.52 |
Total male and female | 0 to 15 years | S01G Decongestants and antiallergics | 2022* | 1.18 |
Total male and female | 15 to 25 years | A Alimentary tract and metabolism | 2022* | 8.10 |
Total male and female | 15 to 25 years | A02B Drugs for peptic ulcer and gord | 2022* | 1.08 |
Total male and female | 15 to 25 years | A03B Belladonna and derivatives, plain | 2022* | 0.01 |
Total male and female | 15 to 25 years | A03E Antispasmodics and anticholinergics | 2022* | 0.00 |
Total male and female | 15 to 25 years | A04 Antiemetics and antinauseants | 2022* | 0.43 |
Total male and female | 15 to 25 years | A04A Antiemetics and antinauseants | 2022* | 0.43 |
Total male and female | 15 to 25 years | A05 Bile and liver therapy | 2022* | 0.03 |
Total male and female | 15 to 25 years | A05C Bile therapy drugs and lipotropics | 2022* | 0.00 |
Total male and female | 15 to 25 years | A10A Insulins and analogues | 2022* | 0.44 |
Total male and female | 15 to 25 years | A11C Vit A and D, incl.combin.of the two | 2022* | 2.48 |
Total male and female | 15 to 25 years | A11D Vitamin B1,and with vit. B6 and B12 | 2022* | 0.00 |
Total male and female | 15 to 25 years | A16A Oth.aliment.tract and metabol.prod. | 2022* | 0.01 |
Source: CBS. |
Dataset is not available.
This table contains figures on the absolute number of persons to whom in the year concerned medicines were dispensed for which the costs are reimbursed under the statutory basic medical insurance. Also, the number of dispensed defined daily doses (DDDs) are presented. The figures are also expressed as a percentage of the total population in the category concerned. The population includes everybody registered in the Personal Records Database (BRP) and living in the Netherlands at some point in the year concerned. Until 2010 the figures also included medicines dispensed to persons registered in the BRP, but no longer resident in the Netherlands.
Medicines provided to persons in hospitals and nursing homes are not included; medicines provided in residential homes for the elderly are included.
Data are broken down by medicine group, age and sex.
Data available from: 2006
Status of the figures:
Figures for 2022 are provisional.
Changes as of December 20, 2023:
- Provisional figures for 2022 have been added, provisional figures of 2020 and 2021 have been made definite.
- Textual change: the description of drug group Y (Not filled in) has been replaced by Z (Not applicable). However, the underlying resources have remained the same. This category is assigned to products that do not have an ATC code according to the WHO ATC classification system.
When will new figures be published?
New figures will be published in the last quarter of 2024.
Description topics
- Persons with medicines, relative
- Number of persons to whom medicines are dispensed in the year concerned that are reimbursed under the statutory basic medical insurance, expressed as a percentage of the total population of the category concerned registered in the Basic Registration of Persons (BRP) in that year.